Abbott Corp., Orlando, Florida, has been awarded a maximum $119,506,023 indefinite-delivery/indefinite-quantity contract for over-the-counter antigen test kits. This was a competitive acquisition with three responses received. This is a one-year contract with no option periods. Location of performance is all 50 states, with a Sept. 14, 2022, ordering period end date. Primary customer is the Department of Health and Human Services. Type of appropriation is fiscal 2021 through 2022 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DE-21-D-0048). (Awarded Sept. 14, 2021.